Cystatin C is a small protein filtered by the kidneys whose blood level reflects glomerular filtration with much less dependence on muscle mass than creatinine. That makes cystatin C based eGFR especially useful when creatinine is likely to mislead, and the combined equation is the most accurate estimate available without a measured GFR study.
How it works
Both equations are the 2021 race-free CKD-EPI forms. The cystatin C only equation scales a base rate by how far cystatin C sits above or below a reference of 0.8 mg/L, then applies age and sex factors:
eGFR(cys) = 133 x min(Scys/0.8, 1)^-0.499
x max(Scys/0.8, 1)^-1.328
x 0.996^age
x (0.932 if female)
The combined equation uses both markers, with creatinine handled through sex-specific kappa and alpha constants, and is the most accurate of the three.
Staging and when to prefer cystatin C
The result is mapped to KDIGO GFR categories: G1 at 90 or above, G2 from 60 to 89, G3a from 45 to 59, G3b from 30 to 44, G4 from 15 to 29, and G5 below 15. Reach for cystatin C or the combined equation when creatinine alone is suspect, for example in someone with very high or very low muscle mass, before high-stakes drug dosing, or to confirm chronic kidney disease found on a creatinine estimate. The combined equation is the recommended confirmatory tool because it draws on both markers at once.